4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-13-053649
SVP & Chief Commercial Officer sold 107,500 shares at an average $12.03 ($1,293,277)
- SVP & Chief Commercial Officer acquired 98,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Repella Robert · SVP & Chief Commercial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-11-19 | Sale : show line 1 in the form | −2,885 | $12.07 | $34,829 | 21,490 | D |
| 2013-11-20 | Exercise or conversion : show line 2 in the form | +40,515 | $5.90 | $239,039 | 62,005 | D |
| 2013-11-20 | Sale : show line 3 in the form | −40,515 | $11.89 | $481,659 | 21,490 | D |
| 2013-11-21 | Exercise or conversion : show line 4 in the form | +23,040 | $5.90 | $135,936 | 44,530 | D |
| 2013-11-21 | Exercise or conversion : show line 5 in the form | +34,570 | $3.12 | $107,858 | 79,100 | D |
| 2013-11-21 | Sale : show line 6 in the form | −64,100 | $12.12 | $776,789 | 15,000 | D |
| Open-market sales · 107,500 sh · avg $12.03 · $1,293,277 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-11-20 | Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) | −40,515 | $5.90 | 2021-10-24 | 40,515 | 189,485 | D |
| 2013-11-21 | Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) | −23,040 | $5.90 | 2021-10-24 | 23,040 | 166,445 | D |
| 2013-11-21 | Exercise or conversion : show line 9 in the form Employee Stock Option (Right to Buy) | −34,570 | $3.12 | 2022-12-06 | 34,570 | 21,680 | D |
Loading xslF345X03/doc4.xml…